Event cover
AvatarAvatarAvatarAvatarAvatarAvatarAvatar
Ayub and 23 more

Generative AI for Drug Discovery & Development

27 Aug, 6:30 PM  ·  Camden

Event details

about us: the Tech Trends & Talent, a Networking Group is a unique event designed to bring together professionals, entrepreneurs, and innovators in the technology sector. This gathering aims to foster connections, share insights, and explore the latest trends shaping the tech landscape. event: generative AI for Drug Discovery & Development: Evening with Nikolay Burlutskiy Join us for this insightful evening to explore the revolutionary impact of generative AI in drug discovery and development, led by one of the industry's leading expert - Nikolay Burlutskiy. The event is organised by Kuinji.com and hosted at TelosHouse.com (Enclave Penthouse, KX) 18:00 - Arrival and Welcome - Meet at the penthouse (Enclave, Kings Cross) - Mingle, drinks, and networking 18:30 - Keynote Presentation by Dr. Nikolay Burlutskiy, Director of AI at AstraZeneca - Topic: "Generative AI for Drug Discovery & Development" - Exploring cutting-edge applications of AI in the pharmaceutical industry - Insights on accelerating drug development timelines and enhancing precision in creating novel therapeutics 19:15 - Interactive Q&A Session - Engage directly with Dr. Burlutskiy - Discuss the future implications of AI in pharmaceuticals 19:45 - Extended Networking - Continue discussions and forge connections with fellow attendees 20:45 - Informal Gathering - Move to a bar at Granary Square for continued conversations and networking Please note: *** Code of Conduct: This event follows the NumFOCUS Code of Conduct https://numfocus.org/code-of-conduct. Please get in touch with the organisers with any questions or concerns regarding the Code of Conduct. *** There'll be only free soft drinks, no alcohol I'm afraid. ***

Ayub Y
Event host
Event host's avatar
27 Aug, 6:30 PM
Tuesday
Camden
Exact location available after joining
Capacity for 50 people
Limited number of spaces available

Participants24